
In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotech companies, what Covid taught us about science and public health, and how new technologies like AI might change how we do science altogether. TPM E52 highlights >Episode 52 links:Ian Simon on LinkedInAspis Intelligence
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Kamal Jethwani | The concierge CEO: Incubating the next generation of digital oncology companies | TPM podcast #56

Shakti Ramkissoon | The Pulse of the Oncologist: Meeting clinicians and patients where they are to deliver precision medicine | TPM podcast #55

Sean Khozin | The rhythm and dissonance of cancer biology | TPM podcast #54

Colette Delawalla | Be the change you want to see in the world: mobilizing to protect American science | TPM podcast #53
Free AI-powered recaps of Talking Precision Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.